{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
m midodrine
to a specific field?
Status:
Investigational
Source:
INN:ormutivimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:precemtabart tocentecan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:rimteravimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:efitazanamivir alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:efclarofusp alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ziralimumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01373450: Phase 1 Interventional Completed Type 2 Diabetes Mellitus
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03534063: Not Applicable Interventional Completed Pain, Postoperative
(2018)
Source URL:
Class:
PROTEIN
